SCHEMBL31201095

SCHEMBL31201095

CC[C@H](CO)Nc1cc(Nc2ccccn2)c2nnc(C(C)C)n2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 14/20 0.46
▸ CDK5 Q00535 13/20 0.46
▸ CDK5R1 Q15078 13/20 0.46
▸ CDK2 P24941 11/20 0.46
▸ CCNA2 P20248 10/20 0.46
▸ CCNA1 P78396 2/20 0.46
▸ CCNT1 O60563 11/20 0.39
▸ CDK9 P50750 11/20 0.39
▸ DYRK2 Q92630 11/20 0.39
▸ DYRK1B Q9Y463 11/20 0.39
▸ DYRK3 O43781 10/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ CDK7 P50613 2/20 0.38
▸ CLK1 P49759 1/20 0.37
▸ CLK2 P49760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201166 0.94 GABRA1 (0.41) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201113 0.85 DYRK1A (0.41) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201383 0.82 GABRA1 (0.36) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201386 0.82 GABRA1 (0.33) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201375 0.81 CDK7 (0.53) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201227 0.81 CDK7 (0.53) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201240 0.81 CCNA2 (0.39) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201150 0.80 TYK2 (0.36) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201130 0.80 CCNA2 (0.33) DYRK1ACDK5CDK5R1CDK2CCNA2
SCHEMBL31201350 0.78 GABRA1 (0.33) DYRK1ACDK5CDK5R1CDK2CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback